Lm. Mulligan et al., GENOTYPE-PHENOTYPE CORRELATION IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-2- REPORT OF THE INTERNATIONAL-RET-MUTATION-CONSORTIUM, Journal of internal medicine, 238(4), 1995, pp. 343-346
The International RET Mutation Consortium was first convened as part o
f the Fifth International Workshop on Multiple Endocrine Neoplasia, St
ockholm, Sweden, in an attempt to analyse the relationship of RET muta
tion and disease phenotype in the autosomal dominantly inherited multi
ple endocrine neoplasia type 2 (MEN 2) syndromes. Out of 361 families
studied, 41% had MEN 2A, 17.7% MEN 2B, 6.4% FMTC and the remaining sub
jects were unclassified, RET mutations were detected in 87.3% of famil
ies overall. Over 93% of MEN 2B families had the RET 918 ATG --> ACG m
utation, while the most frequent mutation detected in MEN 2A families
was cysteine codon 634 (87% of all mutations).